Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages.
暂无分享,去创建一个
[1] D. Remick,et al. The pathogenesis of sepsis. , 2011, Annual review of pathology.
[2] L. Furci,et al. Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. , 2007, Blood.
[3] 山本 雅裕. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway , 2006 .
[4] P. Lusso,et al. HIV and the chemokine system: 10 years later , 2006, The EMBO journal.
[5] A. Verani,et al. Macrophages and HIV-1: dangerous liaisons. , 2005, Molecular immunology.
[6] K. Triantafilou,et al. Invited review: The dynamics of LPS recognition: complex orchestration of multiple receptors , 2005, Journal of endotoxin research.
[7] F. Blasi,et al. The role of urokinase‐type plasminogen activator (uPA)/uPA receptor in HIV‐1 infection , 2003, Journal of leukocyte biology.
[8] J. Levy,et al. α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors , 2003, AIDS.
[9] M. Bukrinsky,et al. β-Chemokine production in CD40L-stimulated monocyte-derived macrophages requires activation of MAPK signaling pathways , 2003 .
[10] Theresa L. Chang,et al. CAF-Mediated Human Immunodeficiency Virus (HIV) Type 1 Transcriptional Inhibition Is Distinct from α-Defensin-1 HIV Inhibition , 2003, Journal of Virology.
[11] Ruslan Medzhitov,et al. Toll-Like Receptor Signaling Pathways , 2003, Science.
[12] F. Barré-Sinoussi,et al. Fcγ Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages , 2003, Journal of Virology.
[13] Shuang Huang,et al. Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-kappa B activation in human peripheral blood monocytes. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[14] E. Dalmasso,et al. Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor , 2002, Science.
[15] A. Siccardi,et al. Inhibition of CXCR4-Tropic HIV-1 Infection by Lipopolysaccharide: Evidence of Different Mechanisms in Macrophages and T Lymphocytes1 , 2002, The Journal of Immunology.
[16] K. Kedzierska,et al. Cytokines and HIV-1: Interactions and Clinical Implications , 2001, Antiviral chemistry & chemotherapy.
[17] H. Gendelman,et al. Regulation of Human Immunodeficiency Virus Type 1 Infection, β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry , 2001, Journal of Virology.
[18] M. Malim,et al. Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding , 2000, Journal of Virology.
[19] H. Jörnvall,et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. , 2000, Blood.
[20] M. Bukrinsky,et al. Lipopolysaccharide Inhibits HIV-1 Infection of Monocyte- Derived Macrophages Through Direct and Sustained Down-Regulation of CC Chemokine Receptor 51 , 2000, The Journal of Immunology.
[21] O. Nishimura,et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. McIntyre,et al. LPS-Induced NF-κB Activation and TNF-α Release in Human Monocytes Are Protein Tyrosine Kinase Dependent and Protein Kinase C Independent , 1999 .
[23] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[24] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[25] M. Giacca,et al. C–C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells , 1997, The Journal of experimental medicine.
[26] J. Silver,et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. , 1996, Immunity.
[27] S. Amar,et al. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. , 1994, Journal of immunology.
[28] T. Kirikae,et al. Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] M. Lotz,et al. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. , 1993, Journal of immunology.
[30] R. Locksley,et al. Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression. , 1991, The Journal of clinical investigation.
[31] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[32] D. Richman,et al. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro , 1989, The Journal of experimental medicine.
[33] K. Triantafilou,et al. The dynamics of LPS recognition: complex orchestration of multiple receptors , 2005 .
[34] M. Clerici,et al. Human alpha defensin in HIV-exposed but uninfected individuals. , 2004, Journal of acquired immune deficiency syndromes.
[35] M. Bukrinsky,et al. beta-Chemokine production in CD40L-stimulated monocyte-derived macrophages requires activation of MAPK signaling pathways. , 2003, Cytokine.
[36] S. Akira,et al. Toll-like receptors. , 2003, Annual review of immunology.
[37] E. Dalmasso,et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. , 2002, Science.
[38] R. McIntyre,et al. LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent. , 1999, Journal of Surgical Research.